4Milne SE,Troy A, Irwin MG, et al. Relationship between bispec- tral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. Br J Anaesth, 2003,90 (2) :127-131.
5Roberts RG, Redman JW. Etomidate,adrenal dysfunction and criti- cal care. Anaesthesia,2002,57(4) :413.
7Schraag S, Pawlik M, Mohl U, et al. The role of ase or bieacid nad xylitol in etomidate-induced adrenocortical suppression in hu- mans. Eur J Anaesthesiol, 1996,13 (4) :346-351.
8Xie Z, Currie KP, Fox AP. Etomldate elevates intracellular calci- um levels and promotes catecholamine secretion in bovine chro- maffin cells. J Physio1,2004,560( Pt 3) :677-690.
9Doenicke AW, Roizen MF, Hoernecke R, et al. TIVA with etomid- ate in day-case surgery :is inhibition of cortisol secretion by etomi- date a limiter factor. Anesth Analg, 1999,88 (2S) :542-549.
10Moody EJ, Knauer CS, Granj AR, et al. Distinct structural requirements t'or direct and indirect actions of the anaesthetic etomidate at GABAA receptors. Toxicol Lett, 1998,100-101;209-215.
